Hinokiflavone as a Potential Antitumor Agent: From Pharmacology to Pharmaceutics
Open Access
Abstract
Hinokiflavone (HF), a natural C-O-C-linked biflavonoid originally isolated from Chamaecyparis obtusa, is a promising multifunctional antitumor agent. Despite challenges posed by multidrug resistance and tumor heterogeneity, HF demonstrates notable therapeutic potential through a multifaceted pharmacological profile. HF exerts broad-spectrum anticancer effects by targeting multiple oncogenic pathways, including the MDM2-p53 axis, MAPK/JNK/NF-κB signaling, ROS/JNK-mediated apoptosis, and Bcl-2/Bax-regulated mitochondrial pathways. These actions are further complemented by inhibition of cell proliferation through cell cycle arrest and suppression of metastasis via downregulation of matrix metalloproteinases and reversal of epithelial–mesenchymal transition. Additionally, HF displays antioxidant, anti-inflammatory, and antimicrobial activities, enhancing treatment efficacy. However, its clinical translation remains limited by poor aqueous solubility, low oral bioavailability, and incomplete pharmacokinetic characterization. Recent advances in nanotechnology-based formulation strategies, such as polymeric micelles and metal–organic frameworks, have enhanced HF’s bioavailability and in vivo antitumor efficacy. This review comprehensively delineates HF’s molecular mechanisms of anticancer action, evaluates its pharmacokinetics and bioformulation developments, and highlights challenges and prospects for clinical application. Integration of tumor microenvironment-responsive delivery systems with synergistic therapeutic strategies is essential to fully realize HF’s therapeutic potential, positioning it as a valuable scaffold for novel anticancer drug development.Keywords
Funding Information
- State Key Laboratory of Neurology and Oncology Drug Development (SKLSIM-20250182)
This publication has 142 references indexed in Scilit:
- Network pharmacology and experimental study on the inhibition of glycolysis by amentoflavone in pancreatic cancerDiscover Oncology, 2025
- Staphylococcus aureus AgrA Modulators From South African Antimicrobial PlantsChemistry & Biodiversity, 2025
- Amentoflavone induces caspase‐dependent/−independent apoptosis and dysregulates cyclin‐dependent kinase‐mediated cell cycle in colorectal cancer in vitro and in vivoEnvironmental Toxicology, 2023
- Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK/mTOR/ERK signalingCellular and Molecular Life Sciences, 2022
- Hinokiflavone and Related C–O–C-Type Biflavonoids as Anti-cancer Compounds: Properties and Mechanism of ActionNatural Products and Bioprospecting, 2021
- Mechanical Regulation of Apoptosis in the Cardiovascular SystemAnnals of Biomedical Engineering, 2020
- Hinokiflavone induces apoptosis and inhibits migration of breast cancer cells via EMT signalling pathwayCell Biochemistry and Function, 2020
- Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumorsMolecular Oncology, 2018
- Development and validation of an LC–MS/MS method for the determination of hinokiflavone in rat plasma and its application to a pharmacokinetic studyBiomedical Chromatography, 2016
- Synthesis of Biologically Relevant Biflavanoids – A ReviewChemistry & Biodiversity, 2007